G P Ventresca

482 total citations
17 papers, 396 citations indexed

About

G P Ventresca is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, G P Ventresca has authored 17 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 5 papers in Physiology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in G P Ventresca's work include Inhalation and Respiratory Drug Delivery (6 papers), Asthma and respiratory diseases (5 papers) and Pharmaceutical studies and practices (4 papers). G P Ventresca is often cited by papers focused on Inhalation and Respiratory Drug Delivery (6 papers), Asthma and respiratory diseases (5 papers) and Pharmaceutical studies and practices (4 papers). G P Ventresca collaborates with scholars based in Italy, United Kingdom and Sweden. G P Ventresca's co-authors include Alison E. Mackie, Alan Bye, Jonathan K. Ward, Richard W. Fuller, Stefano Milleri, Jan Lötvall, Mona Palmqvist, Peter Arvidsson, Alan Maloney and Antonio Longo and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Thorax and British Journal of Clinical Pharmacology.

In The Last Decade

G P Ventresca

17 papers receiving 356 citations

Peers

G P Ventresca

PRM

PHYSI

ASZ

P. Koch Germany

Adrian Pereira United Kingdom

A.D. Mackay United Kingdom

George Perentesis United States

Rashmi Mehta United States

Jerry Herron United States

J. Gerloff Germany

Khalid Al-Balushi Oman

G. Leopold Germany

David M. Soda United States

P. Koch Germany

G P Ventresca

68 ×0.3

PRM

56 ×0.2

PHYSI

37 ×0.5

ASZ

38 ×0.9

70 ×1.8

Citations per year, relative to G P Ventresca G P Ventresca (= 1×) peers P. Koch

Countries citing papers authored by G P Ventresca

Since Specialization

Citations

This map shows the geographic impact of G P Ventresca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G P Ventresca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G P Ventresca more than expected).

Fields of papers citing papers by G P Ventresca

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G P Ventresca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G P Ventresca. The network helps show where G P Ventresca may publish in the future.

Co-authorship network of co-authors of G P Ventresca

This figure shows the co-authorship network connecting the top 25 collaborators of G P Ventresca. A scholar is included among the top collaborators of G P Ventresca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G P Ventresca. G P Ventresca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Kirby, Suyong Yun, Christine Falcoz, Matthieu Daniel, et al.. (2001). Salmeterol and fluticasone propionate given as a combination. European Journal of Clinical Pharmacology. 56(11). 781–791. 40 indexed citations

Lötvall, Jan, Mona Palmqvist, Peter Arvidsson, et al.. (2001). The therapeutic ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic patients. Journal of Allergy and Clinical Immunology. 108(5). 726–731. 76 indexed citations

Ward, Jonathan K., Julian A. T. Dow, Nigel Dallow, et al.. (2000). Enantiomeric disposition of inhaled, intravenous and oral racemic‐salbutamol in man — no evidence of enantioselective lung metabolism. British Journal of Clinical Pharmacology. 49(1). 15–22. 51 indexed citations

Mackie, Alison E., et al.. (1997). Pharmacokinetics and Bioavailability of Intranasal Fluticasone in Humans. Clinical Drug Investigation. 14(1). 44–52. 24 indexed citations

Mackie, Alison E., G P Ventresca, Richard W. Fuller, & Alan Bye. (1996). Pharmacokinetics of intravenous fluticasone propionate in healthy subjects. British Journal of Clinical Pharmacology. 41(6). 539–542. 67 indexed citations

Mariani, Luigi, et al.. (1996). [Drug surveillance and adverse reactions to drugs. The literature and importance of historical data].. PubMed. 147(12). 653–72. 4 indexed citations

Ventresca, G P, et al.. (1996). [Disease states and changes in drug pharmacokinetics].. PubMed. 147(3). 131–44. 5 indexed citations

Ventresca, G P. (1995). Clinical Pharmacology of HFA134a. Journal of Aerosol Medicine. 8(s1). S–35. 15 indexed citations

Smith, John A., et al.. (1995). Salmeterol inhaler using a non-chlorinated propellant, HFA134a: systemic pharmacodynamic activity in healthy volunteers.. Thorax. 50(6). 679–681. 10 indexed citations

10.

Mackie, Alison E., et al.. (1995). Very low systemic exposure to intranasal fluticasone propionate. 2. 194. 12 indexed citations

11.

Aigbirhio, Franklin I., B C Page, C. G. Rhodes, et al.. (1995). Disposition of inhaled 1,1,1,2-tetrafluoroethane (HFA134A) in healthy subjects and in patients with chronic airflow limitation. Measurement by 18F-labeling and whole-body gamma-counting.. Drug Metabolism and Disposition. 23(8). 832–839. 11 indexed citations

12.

Simone, P., et al.. (1990). Dose-response comparison of broxaterol and salbutamol pressurized aerosols. European Journal of Clinical Pharmacology. 39(6). 565–568. 6 indexed citations

13.

Rochebrochard, Élise de La, et al.. (1989). Pharmacokinetics and bioavailability of oral acetylcysteine in healthy volunteers.. PubMed. 39(3). 382–6. 58 indexed citations

14.

De, Liu, et al.. (1988). Ibopamine kinetics after single and multiple dosing in patients with congestive heart failure.. PubMed. 26(11). 544–51. 6 indexed citations

15.

Ventresca, G P, et al.. (1988). Clinical pharmacokinetics of ibopamine on different diseases and conditions.. PubMed. 38(8). 1175–80. 5 indexed citations

16.

Catto, G. R. D., Giuseppe Iacuitti, Gualtiero Pelosi, et al.. (1988). Ibopamine kinetics after a single oral dose in patients with congestive heart failure.. PubMed. 26(2). 105–12. 5 indexed citations

17.

Ventresca, G P, et al.. (1986). Viminol R2 analgesic activity in patients with postoperative pain: comparison with pentazocine.. PubMed. 24(5). 232–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact